Show simple item record

Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma.

dc.contributor.authorMorschhauser, Fen
dc.contributor.authorDyer, MJSen
dc.contributor.authorWalter, HSen
dc.contributor.authorDanilov, AVen
dc.contributor.authorYsebaert, Len
dc.contributor.authorHodson, DJen
dc.contributor.authorFegan, Cen
dc.contributor.authorRule, SAen
dc.contributor.authorRadford, Jen
dc.contributor.authorCartron, Gen
dc.contributor.authorBouabdallah, Ken
dc.contributor.authorDavies, AJen
dc.contributor.authorSpurgeon, Sen
dc.contributor.authorRajakumaraswamy, Nen
dc.contributor.authorLi, Ben
dc.contributor.authorHumeniuk, Ren
dc.contributor.authorHuang, Xen
dc.contributor.authorBhargava, Pen
dc.contributor.authorJürgensmeier, JMen
dc.contributor.authorSalles, Gen
dc.date.accessioned2021-10-19T08:55:30Z
dc.date.issued2021-07en
dc.identifier.issn0887-6924en
dc.identifier.urihttp://hdl.handle.net/10026.1/18096
dc.format.extent2108 - 2113en
dc.languageengen
dc.language.isoengen
dc.publisherSpringer Nature [academic journals on nature.com]en
dc.subjectAdulten
dc.subjectAgeden
dc.subjectAntineoplastic Agentsen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectImidazolesen
dc.subjectIndazolesen
dc.subjectLymphoma, B-Cellen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectProtein Kinase Inhibitorsen
dc.subjectPurinesen
dc.subjectPyrazinesen
dc.subjectPyrimidinesen
dc.subjectQuinazolinonesen
dc.titlePhase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma.en
dc.typeJournal Article
plymouth.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/33328591en
plymouth.issue7en
plymouth.volume35en
plymouth.journalLeukemiaen
dc.identifier.doi10.1038/s41375-020-01108-xen
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/Faculty of Health/Peninsula Medical School
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine/UoA01 Clinical Medicine
plymouth.organisational-group/Plymouth/Research Groups
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CBR
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CCT&PS
plymouth.organisational-group/Plymouth/Users by role
plymouth.organisational-group/Plymouth/Users by role/Academics
dcterms.dateAccepted2020-11-30en
dc.rights.embargodate2021-10-20en
dc.identifier.eissn1476-5551en
dc.rights.embargoperiodNot knownen
rioxxterms.versionofrecord10.1038/s41375-020-01108-xen
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden
rioxxterms.licenseref.startdate2021-07en
rioxxterms.typeJournal Article/Reviewen


Files in this item

Thumbnail
Name:
UoP_Deposit_Agreement v1.1 ...
Size:
125.4Kb
Format:
PDF
View/Open
Thumbnail
Name:
s41375-020-01108-x.pdf
Size:
466.6Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record

All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
PEARL Guides and Policies | PEARL Reports | Contact Us | Send Feedback
Theme by 
@mire NV